DRUG:NASDAQ
Bright Minds Biosciences Inc
$52.00
0.00%
(0.00) 1D
$52.00
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 8, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DRUG...
Open
$51.01
High
$52.64
Low
$49.29
Mkt. cap
722.61M
Avg. vol.
113.76K
Volume
67.92K
52-wk high
$123.75
52-wk low
$47.35
Beta
-5.21
Shares outstanding
9.86M
No. of employees
26
Open
$51.01
High
$52.64
Low
$49.29
Mkt. cap
722.61M
Avg. vol.
113.76K
Volume
67.92K
52-wk high
$123.75
52-wk low
$47.35
Beta
-5.21
Shares outstanding
9.86M
No. of employees
26
News stories
From web sources and news partners
Yahoo Finance
·
14 hours ago
Bright Minds Biosciences And 2 More Canadian Biotech Stocks
Profile
Bright Minds Biosciences is an American pharmaceutical company which is developing serotonin 5-HTâ‚‚ receptor agonists for potential medical use.
It has a particular focus on serotonin 5-HT2C receptor agonists, for instance to treat rare epilepsies and other conditions. Another area of focus for the company is serotonergic psychedelics and non-hallucinogenic psychoplastogens.
The company was co-founded by Ian McDonald and Gideon Shapiro. The lead scientist at Bright Minds Biosciences was previously Alan Kozikowski. Bright Mind Biosciences was founded in 2017 and its headquarters are in New York City, New York. Wikipedia
About Bright Minds Biosciences Inc